The finding in preclinical models that AChE exerts neuroprotective effects mediated by α7nAChR and modulates innate immunity, possibly as a result of the increased availability of acetylcholine activating the CAIP, paves the way for new pharmacological intervention in AD and other neurological disorders characterized by neuroinflammation [5]. This evidence concerns the gene CHRNA7 and Alzheimer disease.